Company news

GeneDx Holdings Corp. news in 2026

GeneDx Holdings Corp.'s news releases, calls and decks from 2026, newest first.

View company

GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing

November 5, 2026

GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026

October 23, 2026

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

October 20, 2026

GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026

October 19, 2026

GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026

October 7, 2026

GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care

October 2, 2026

GeneDx Reports Second Quarter 2026 Financial Results

August 3, 2026

GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026

July 16, 2026

GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 26, 2026

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook

May 4, 2026

GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026

April 12, 2026

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing

March 11, 2026

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

March 9, 2026

GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership

March 8, 2026

INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

February 23, 2026

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

February 22, 2026

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health

February 11, 2026

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

February 2, 2026

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

January 12, 2026

GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset

January 8, 2026

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

January 7, 2026

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

January 5, 2026

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

January 4, 2026

Calls in 2026

Decks in 2026